Executable hardening sequence improves gauge-running results and proton-decay predictions in grand-unification framework.
The QDL–SO10–1 grand-unification sequence defines a closure-first SO(10)-compatible benchmark within the Quantized Dimensional Ledger (QDL) program. The first three papers in the sequence established a fixed numerical benchmark, its low-energy phenomenology, and a robustness/failure-mode audit. The present paper begins the executable hardening sequence. This paper provides the v0.2 executable gauge-running hardening result for QDL–SO10–1. The v0.1 artifact showed that the original declared target αU−1=25.6α_U⁻¹=25.6αU−1=25.6 is not reproduced by the minimal pure-gauge executable scaffold, yielding an old-target RMS residual of 18.92788118.92788118.927881. The v0.2 artifact resolves the dominant residual by revising the executable coupling target to the mean Pati–Salam inverse coupling at MUM_UMU, giving αU,v0.2−1=44.501718αU,v0.2⁻¹=44.501718αU,v0.2−1=44.501718 and αU,v0.2=0.022471αU,v0.2=0.022471αU,v0.2=0.022471. The remaining channel splittings are recorded as calibrated high-scale threshold targets: λ4CU,v0.2=−1.284227λ4CU,v0.2=-1.284227λ4CU,v0.2=−1.284227, λ2LU,v0.2=+0.950018λ2LU,v0.2=+0.950018λ2LU,v0.2=+0.950018, and λ2RU,v0.2=+0.334210λ2RU,v0.2=+0.334210λ2RU,v0.2=+0.334210. With these revised values, the calibrated residual is 2.57×10−72.57×10⁻⁷2.57×10−7. Proton-decay exposure is also rescaled because gauge-mediated lifetimes scale approximately as τp∝αU−2τ_p∝α_U⁻²τp∝αU−2, moving the central p→e+π0p→ e^+π^0p→e+π0 lifetime to 3.324041×10353.324041×10³⁵3.324041×1035 yr. This is a calibrated executable closure result, not yet a full scalar-derived resolution. The next artifact, v0.3, must derive the calibrated threshold offsets from explicit SO(10)→→→Pati–Salam scalar multiplets and Dynkin-index weighted threshold corrections. The final all-inclusive QDL–SO10–1 perspective is deferred until the executable hardening sequence is complete.
No takes yet. Share an insight, caveat, or question.
James D. Bourassa (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: